Hedge fund
ADAR1 Capital Management, LLC
13F for the quarter to June 30, 2026, filed August 14, 2026 · SEC CIK 1940272
- Reported value
- $2.1bn 87% in companies we cover
- Positions we cover
- 229 Largest ABVX 11.4%
- Copy, a year
- +31.1% S&P 500 +17.9%
- Copy Sharpe ratio
- 0.80 S&P 500 0.91
How copying its 13F would have done
Reported value by quarter
View chart data
| Period | Reported value |
|---|---|
| 2023-12-31 | $223.6M |
| 2024-03-31 | $366.3M |
| 2024-06-30 | $496.6M |
| 2024-09-30 | $596.5M |
| 2024-12-31 | $469.4M |
| 2025-03-31 | $505.2M |
| 2025-06-30 | $609.2M |
| 2025-09-30 | $1B |
| 2025-12-31 | $1.3B |
| 2026-03-31 | $1.7B |
| 2026-06-30 | $2.1B |
Holdings and moves
| Company | Share of portfolio | Value | Shares | Change in shares |
|---|---|---|---|---|
| ABVXAbivax S.a. | 11.39% | $240.5m | 1.80M | +29.5% Added |
| PTGXProtagonist Therapeutics, Inc | 5.58% | $117.8m | 960.9K | −3.3% Reduced |
| ROIVRoivant Sciences Ltd. | 5.29% | $111.7m | 3.16M | −3.9% Reduced |
| IMVTImmunovant, Inc. | 4.25% | $89.8m | 2.33M | −13.0% Reduced |
| ZLABZai Lab Ltd | 3.03% | $64.0m | 3.37M | +136.4% Added |
| AGIOAgios Pharmaceuticals, Inc. | 2.26% | $47.8m | 1.29M | +815.6% Added |
| CYTKCytokinetics Inc | 1.85% | $39.0m | 457.9K | −27.6% Reduced |
| SEPNSepterna, Inc. | 1.49% | $31.5m | 940.7K | −13.7% Reduced |
| AVRAnteris Technologies Global Corp. | 1.47% | $31.0m | 3.15M | −17.0% Reduced |
| EDITEditas Medicine, Inc. | 1.36% | $28.8m | 8.89M | New |
| DNLIDenali Therapeutics Inc. | 1.25% | $26.5m | 1.03M | −45.0% Reduced |
| SYRESpyre Therapeutics, Inc. | 1.19% | $25.2m | 284.0K | −16.1% Reduced |
| VIRVir Biotechnology, Inc. | 1.19% | $25.0m | 2.46M | −10.5% Reduced |
| PRAXPraxis Precision Medicines, Inc. | 1.18% | $24.9m | 74.3K | +4850.2% Added |
| INSMInsmed Inc | 1.15% | $24.4m | 228.5K | +545.7% Added |
| CLDXCelldex Therapeutics, Inc. | 1.09% | $23.1m | 619.5K | +44.8% Added |
| VKTXViking Therapeutics, Inc. | 1.06% | $22.4m | 574.0K | +152.1% Added |
| TSHATaysha Gene Therapies, Inc. | 0.98% | $20.7m | 3.04M | +2.0% Added |
| MNPRMonopar Therapeutics | 0.95% | $20.1m | 217.6K | −17.7% Reduced |
| OVIDOvid Therapeutics Inc. | 0.94% | $20.0m | 7.42M | +63.2% Added |
| ELVNEnliven Therapeutics, Inc. | 0.93% | $19.7m | 387.7K | +17.7% Added |
| ENTAEnanta Pharmaceuticals Inc | 0.93% | $19.6m | 1.34M | +2518.0% Added |
| NKTRNektar Therapeutics | 0.81% | $17.0m | 244.2K | +51.4% Added |
| INSPInspire Medical Systems, Inc. | 0.79% | $16.7m | 374.6K | −7.5% Reduced |
| RVMDRevolution Medicines, Inc. | 0.78% | $16.4m | 87.5K | −34.6% Reduced |
| ESTAEstablishment Labs Holdings Inc. | 0.75% | $15.9m | 185.6K | −13.0% Reduced |
| PRTAProthena Corp Public LTD Co | 0.72% | $15.2m | 1.55M | −1.7% Reduced |
| RYTMRhythm Pharmaceuticals, Inc. | 0.72% | $15.1m | 136.2K | −35.6% Reduced |
| IKTInhibikase Therapeutics, Inc. | 0.71% | $15.0m | 7.39M | +11.8% Added |
| QUREUniqure N.V. | 0.71% | $15.0m | 324.7K | +326.0% Added |
| RLYBRallybio Corp | 0.70% | $14.8m | 926.4K | +4411.1% Added |
| REGNRegeneron Pharmaceuticals | 0.66% | $13.8m | 22.2K | +82.7% Added |
| IVAInventiva S.a. | 0.65% | $13.6m | 3.61M | +65.9% Added |
| STROSutro Biopharma, Inc. | 0.64% | $13.4m | 404.0K | −23.0% Reduced |
| IONSIonis Pharmaceuticals Inc | 0.62% | $13.2m | 166.3K | +3.7% Added |
| BBIOBridgebio Pharma, Inc. | 0.62% | $13.2m | 176.7K | +87.4% Added |
| SRPTSarepta Therapeutics, Inc. | 0.62% | $13.1m | 730.6K | +178.8% Added |
| CTMXCytomx Therapeutics, Inc. | 0.60% | $12.6m | 3.37M | −1.3% Reduced |
| VORVor Biopharma Inc. | 0.59% | $12.5m | 680.6K | New |
| EQEquillium, Inc. | 0.57% | $12.0m | 3.76M | +0.9% Added |
| ANLAdlai Nortye Group Ltd. | 0.55% | $11.7m | 1.02M | +763.2% Added |
| CLYMClimb Bio, Inc. | 0.51% | $10.7m | 822.6K | +37.6% Added |
| ZURAZura Bio Ltd | 0.49% | $10.4m | 1.76M | +179.1% Added |
| OKUROnkure Therapeutics, Inc. | 0.48% | $10.2m | 2.24M | −8.1% Reduced |
| MAZEMaze Therapeutics, Inc. | 0.48% | $10.1m | 339.3K | +577.3% Added |
| XENEXenon Pharmaceuticals Inc. | 0.48% | $10.1m | 166.6K | −27.2% Reduced |
| TEVATeva Pharmaceutical Industries LTD | 0.45% | $9.4m | 277.8K | +3.5% Added |
| URGNUrogen Pharma Ltd. | 0.44% | $9.3m | 252.4K | −36.2% Reduced |
| FTHFaeth Therapeutics, Inc. | 0.43% | $9.0m | 361.0K | New |
| AMLXAmylyx Pharmaceuticals, Inc. | 0.42% | $8.9m | 494.4K | −50.6% Reduced |
| DBVTDBV Technologies S.a. | 0.41% | $8.7m | 528.3K | −47.8% Reduced |
| SVRASavara Inc | 0.41% | $8.6m | 1.40M | −4.2% Reduced |
| PCVXVaxcyte, Inc. | 0.40% | $8.5m | 146.0K | −43.6% Reduced |
| CGONCG Oncology, Inc. | 0.40% | $8.4m | 118.7K | −36.1% Reduced |
| MLYSMineralys Therapeutics, Inc. | 0.38% | $8.1m | 298.9K | +93.2% Added |
| ASNDAscendis Pharma A/s | 0.36% | $7.6m | 28.6K | New |
| NRIXNurix Therapeutics, Inc. | 0.36% | $7.6m | 313.2K | +458.7% Added |
| BHVNBiohaven Ltd. | 0.35% | $7.5m | 501.7K | +1020.4% Added |
| PRMEPrime Medicine, Inc. | 0.35% | $7.4m | 2.00M | +1.2% Added |
| IRDOpus Genetics, Inc. | 0.35% | $7.3m | 1.78M | −3.5% Reduced |
| LXEOLexeo Therapeutics, Inc. | 0.34% | $7.3m | 1.57M | +6.7% Added |
| REPLReplimune Group, Inc. | 0.34% | $7.3m | 655.8K | −58.6% Reduced |
| LONALeonabio, Inc. | 0.34% | $7.1m | 777.1K | +6.8% Added |
| KRROKorro Bio, Inc. | 0.34% | $7.1m | 540.1K | 0.0% |
| RACCResearch Alliance Corp III | 0.33% | $7.0m | 650.0K | New |
| IFRXInflarx N.V. | 0.32% | $6.7m | 3.00M | +1795.5% Added |
| RLAYRelay Therapeutics, Inc. | 0.32% | $6.7m | 358.3K | New |
| JANXJanux Therapeutics, Inc. | 0.31% | $6.5m | 420.9K | +41.0% Added |
| PLRXPliant Therapeutics, Inc. | 0.30% | $6.3m | 5.51M | +113.1% Added |
| WHWKWhitehawk Therapeutics, Inc. | 0.29% | $6.1m | 1.34M | +943.9% Added |
| KRYSKrystal Biotech, Inc. | 0.29% | $6.1m | 16.4K | −18.0% Reduced |
| ABUSArbutus Biopharma Corp | 0.29% | $6.1m | 1.27M | −59.5% Reduced |
| PFEPfizer | 0.29% | $6.1m | 252.4K | +226.1% Added |
| BHFBrighthouse Financial, Inc. | 0.29% | $6.0m | 95.5K | 0.0% |
| EWTXEdgewise Therapeutics, Inc. | 0.28% | $5.8m | 143.2K | +58.1% Added |
| ALECAlector, Inc. | 0.27% | $5.8m | 2.88M | +174.6% Added |
| FULCFulcrum Therapeutics, Inc. | 0.27% | $5.7m | 1.57M | +1098.7% Added |
| ARWRArrowhead Pharmaceuticals, Inc. | 0.27% | $5.7m | 69.8K | −0.7% Reduced |
| ABOSAcumen Pharmaceuticals, Inc. | 0.27% | $5.6m | 2.11M | −2.1% Reduced |
| GMEDGlobus Medical Inc | 0.26% | $5.5m | 70.1K | +248.8% Added |
| GLUEMonte Rosa Therapeutics, Inc. | 0.25% | $5.2m | 216.8K | +0.5% |
| DHRDanaher Corporation | 0.23% | $4.9m | 25.9K | −16.2% Reduced |
| BOLDBoundless Bio, Inc. | 0.23% | $4.9m | 1.97M | New |
| AVLNAvalyn Pharma Inc. | 0.23% | $4.8m | 146.4K | New |
| SPRYARS Pharmaceuticals, Inc. | 0.23% | $4.8m | 601.0K | −55.9% Reduced |
| PRLDPrelude Therapeutics Inc | 0.23% | $4.8m | 900.9K | +489.5% Added |
| PEPGPepgen Inc. | 0.22% | $4.7m | 2.59M | +61.2% Added |
| CTNMContineum Therapeutics, Inc. | 0.22% | $4.6m | 279.0K | +0.8% Added |
| CATXPerspective Therapeutics, Inc. | 0.20% | $4.1m | 1.21M | +61.5% Added |
| NAMSNewamsterdam Pharma Co N.V. | 0.19% | $4.0m | 118.6K | 0.0% |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | 0.19% | $4.0m | 421.8K | +27.1% Added |
| BIIBBiogen | 0.18% | $3.9m | 17.9K | +62.7% Added |
| XNCRXencor Inc | 0.18% | $3.7m | 232.6K | +148.3% Added |
| SLNSilence Therapeutics plc | 0.18% | $3.7m | 338.4K | +96.5% Added |
| SPRBSpruce Biosciences, Inc. | 0.17% | $3.7m | 67.7K | +15.6% Added |
| PHVSPharvaris N.V. | 0.17% | $3.6m | 105.5K | 0.0% |
| ENGNEngene Therapeutics Inc. | 0.17% | $3.6m | 2.10M | New |
| PALIPalisade BIO, Inc. | 0.17% | $3.6m | 1.73M | −23.8% Reduced |
| TARAProtara Therapeutics, Inc. | 0.17% | $3.6m | 940.5K | 0.0% |
| SGMTSagimet Biosciences Inc. | 0.16% | $3.4m | 437.5K | New |
| ONCBeone Medicines Ltd. | 0.16% | $3.3m | 11.7K | 0.0% |
| IVVDInvivyd, Inc. | 0.16% | $3.3m | 3.81M | −0.4% |
| TENXTenax Therapeutics, Inc. | 0.15% | $3.2m | 220.5K | +3.3% Added |
| ZNTLZentalis Pharmaceuticals, Inc. | 0.15% | $3.2m | 652.8K | +351.3% Added |
| RLMDRelmada Therapeutics, Inc. | 0.15% | $3.1m | 451.9K | 0.0% |
| DCTHDelcath Systems, Inc. | 0.13% | $2.8m | 224.4K | 0.0% |
| BMRNBiomarin Pharmaceutical Inc | 0.13% | $2.8m | 49.0K | +169.2% Added |
| SMMTSummit Therapeutics Inc. | 0.13% | $2.8m | 191.9K | +108.9% Added |
| KROSKeros Therapeutics, Inc. | 0.13% | $2.6m | 246.8K | +153.6% Added |
| ELDNEledon Pharmaceuticals, Inc. | 0.12% | $2.6m | 647.8K | −33.5% Reduced |
| TNGXTango Therapeutics, Inc. | 0.11% | $2.4m | 76.8K | +53.5% Added |
| ISRGIntuitive Surgical | 0.11% | $2.4m | 6.0K | +229.5% Added |
| INOInovio Pharmaceuticals, Inc. | 0.11% | $2.4m | 2.14M | +45.8% Added |
| OABIOmniab, Inc. | 0.11% | $2.3m | 947.4K | +34.3% Added |
| CAPRCapricor Therapeutics, Inc. | 0.10% | $2.2m | 90.6K | 0.0% |
| DRUGBright Minds Biosciences Inc. | 0.10% | $2.1m | 30.3K | −10.6% Reduced |
| ORKAOruka Therapeutics, Inc. | 0.09% | $2.0m | 20.8K | 0.0% |
| MCKMcKesson | 0.09% | $1.9m | 2.5K | +108.3% Added |
| LXRXLexicon Pharmaceuticals, Inc. | 0.09% | $1.8m | 750.0K | 0.0% |
| CRVSCorvus Pharmaceuticals, Inc. | 0.08% | $1.7m | 117.1K | +33.2% Added |
| CUECue Biopharma, Inc. | 0.08% | $1.7m | 55.2K | New |
| MSLESatellos Bioscience Inc. | 0.08% | $1.7m | 222.6K | 0.0% |
| KNSAKiniksa Pharmaceuticals International, plc | 0.08% | $1.7m | 26.9K | 0.0% |
| CNTBConnect Biopharma Holdings Ltd | 0.08% | $1.7m | 700.0K | −5.7% Reduced |
| RCKTRocket Pharmaceuticals, Inc. | 0.07% | $1.5m | 435.5K | +0.7% Added |
| TRAXFirst Tracks Biotherapeutics, Inc. | 0.07% | $1.4m | 71.9K | New |
| EVMNEvommune, Inc. | 0.07% | $1.4m | 104.0K | −43.5% Reduced |
| CCCCC4 Therapeutics, Inc. | 0.07% | $1.4m | 292.0K | +579.0% Added |
| BCRXBiocryst Pharmaceuticals Inc | 0.06% | $1.3m | 133.0K | +26.7% Added |
| SUPNSupernus Pharmaceuticals, Inc. | 0.06% | $1.3m | 27.8K | −6.1% Reduced |
| NVONovo Nordisk A S | 0.06% | $1.3m | 27.0K | −18.2% Reduced |
| AVTRAvantor, Inc. | 0.06% | $1.3m | 130.0K | +62.5% Added |
| INMInmed Pharmaceuticals Inc. | 0.06% | $1.2m | 800.0K | New |
| PMNPromis Neurosciences Inc. | 0.06% | $1.2m | 92.8K | −2.6% Reduced |
| ARTVArtiva Biotherapeutics, Inc. | 0.05% | $1.2m | 118.6K | New |
| TNYATenaya Therapeutics, Inc. | 0.05% | $1.1m | 1.56M | +3.2% Added |
| ALXOALX Oncology Holdings Inc | 0.05% | $1.1m | 533.7K | New |
| AREAlexandria Real Estate Equities | 0.05% | $1.0m | 19.5K | 0.0% |
| RNACCartesian Therapeutics, Inc. | 0.05% | $1.0m | 98.9K | New |
| BNTXBiontech SE | 0.05% | $986,330 | 10.6K | +6.0% Added |
| ACADAcadia Pharmaceuticals Inc | 0.05% | $985,562 | 39.0K | New |
| DYNDyne Therapeutics, Inc. | 0.04% | $951,054 | 42.8K | −9.8% Reduced |
| MPLTMaplight Therapeutics, Inc. | 0.04% | $949,652 | 26.5K | −92.9% Reduced |
| GPCRStructure Therapeutics Inc. | 0.04% | $939,225 | 17.5K | New |
| AURAAura Biosciences, Inc. | 0.04% | $924,079 | 130.2K | New |
| CCXIChurchill Capital Corp XI | 0.04% | $872,500 | 50.0K | New |
| KZIAKazia Therapeutics LTD | 0.04% | $866,624 | 61.5K | New |
| LRMRLarimar Therapeutics, Inc. | 0.04% | $831,872 | 272.7K | +417.1% Added |
| VERAVera Therapeutics, Inc. | 0.04% | $786,197 | 18.3K | +14.3% Added |
| ADGMAdagio Medical Holdings, Inc. | 0.04% | $785,469 | 1.21M | 0.0% |
| Company | Bought (value) | Shares |
|---|---|---|
| ABVXAbivax S.a. | $54.7m | 410.7K |
| AGIOAgios Pharmaceuticals, Inc. | $42.6m | 1.15M |
| ZLABZai Lab Ltd | $36.9m | 1.94M |
| EDITEditas Medicine, Inc. | $28.8m | 8.89M |
| PRAXPraxis Precision Medicines, Inc. | $24.4m | 72.8K |
| INSMInsmed Inc | $20.6m | 193.1K |
| ENTAEnanta Pharmaceuticals Inc | $18.9m | 1.29M |
| RLYBRallybio Corp | $14.5m | 905.8K |
| VKTXViking Therapeutics, Inc. | $13.5m | 346.3K |
| VORVor Biopharma Inc. | $12.5m | 680.6K |
| QUREUniqure N.V. | $11.4m | 248.5K |
| ANLAdlai Nortye Group Ltd. | $10.3m | 899.9K |
| FTHFaeth Therapeutics, Inc. | $9.0m | 361.0K |
| MAZEMaze Therapeutics, Inc. | $8.6m | 289.2K |
| SRPTSarepta Therapeutics, Inc. | $8.4m | 468.6K |
| Company | Sold (value) | Shares |
|---|---|---|
| BEAMBeam Therapeutics Inc. | −$34.5m | −1.45M |
| DNLIDenali Therapeutics Inc. | −$21.7m | −842.4K |
| SRRKScholar Rock Holding Corp | −$20.0m | −407.3K |
| CYTKCytokinetics Inc | −$14.9m | −174.6K |
| IMVTImmunovant, Inc. | −$13.4m | −348.3K |
| MPLTMaplight Therapeutics, Inc. | −$12.5m | −348.4K |
| REPLReplimune Group, Inc. | −$10.3m | −927.2K |
| AMLXAmylyx Pharmaceuticals, Inc. | −$9.1m | −506.2K |
| ABUSArbutus Biopharma Corp | −$9.0m | −1.87M |
| RVMDRevolution Medicines, Inc. | −$8.7m | −46.4K |
| MLTXMoonlake Immunotherapeutics | −$8.4m | −430.1K |
| RYTMRhythm Pharmaceuticals, Inc. | −$8.4m | −75.3K |
| DBVTDBV Technologies S.a. | −$7.9m | −484.6K |
| VRTXVertex Pharmaceuticals | −$6.7m | −15.1K |
| PCVXVaxcyte, Inc. | −$6.6m | −113.1K |
| Company | Value last quarter | Shares |
|---|---|---|
| BEAMBeam Therapeutics Inc. | $34.5m | 1.45M |
| SRRKScholar Rock Holding Corp | $20.0m | 407.3K |
| VRTXVertex Pharmaceuticals | $6.7m | 15.1K |
| VRDNViridian Therapeutics, Inc.\de | $6.0m | 304.4K |
| LLYLilly (Eli) | $4.7m | 5.1K |
| DNTHDianthus Therapeutics, Inc. | $4.6m | 55.0K |
| BLTEBelite BIO, Inc | $4.3m | 26.9K |
| AVBPArrivent Biopharma, Inc. | $3.3m | 141.8K |
| TFXTeleflex Inc | $2.5m | 21.2K |
| BIOABioage Labs, Inc. | $2.4m | 135.6K |
| ALKSAlkermes plc. | $1.6m | 46.4K |
| UNHUnitedHealth Group | $1.5m | 5.5K |
| SXTSensient Technologies Corp | $1.3m | 15.0K |
| SDGRSchrodinger, Inc. | $1.2m | 101.5K |
| FDMT4d Molecular Therapeutics, Inc. | $1.1m | 116.7K |
| BMYBristol Myers Squibb | $1.1m | 17.5K |
| GHGuardant Health, Inc. | $923,700 | 10.0K |
| ITGRInteger Holdings Corp | $770,000 | 8.8K |
| KPTIKaryopharm Therapeutics Inc. | $761,620 | 136.7K |
| CGEMCullinan Therapeutics, Inc. | $710,500 | 50.0K |
| JAZZJazz Pharmaceuticals plc | $567,150 | 3.0K |
| ACRSAclaris Therapeutics, Inc. | $496,598 | 132.4K |
| ELANElanco Animal Health Inc | $478,600 | 20.0K |
| CORZCore Scientific, Inc. | $448,800 | 30.0K |
| SNDXSyndax Pharmaceuticals Inc | $408,800 | 17.5K |
| RGNXRegenxbio Inc. | $372,206 | 44.4K |
| ACETAdicet Bio, Inc. | $366,562 | 53.8K |
| LEGNLegend Biotech Corp | $361,800 | 20.0K |
| SRZNSurrozen, Inc. | $349,560 | 12.0K |
| NBIXNeurocrine Biosciences Inc | $329,350 | 2.5K |
| Period | Copy, a year | S&P 500 | Sharpe | S&P 500 | Biggest drop | Beta |
|---|---|---|---|---|---|---|
| Whole backtestFebruary 16, 2024 to November 2, 2026 | +31.1% | +17.9% | 0.80 | 0.91 | −30.6% | 1.02 |
| Last yearNovember 7, 2025 to November 2, 2026 | +15.6% | +14.2% | 0.51 | 0.84 | −22.5% | 1.13 |